nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ALB—Auranofin—psoriatic arthritis	0.137	0.21	CbGbCtD
Imatinib—ALB—Prednisone—psoriatic arthritis	0.0435	0.0667	CbGbCtD
Imatinib—ABCG2—Dexamethasone—psoriatic arthritis	0.0394	0.0604	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—psoriatic arthritis	0.0375	0.0576	CbGbCtD
Imatinib—ABCG2—Methotrexate—psoriatic arthritis	0.0316	0.0485	CbGbCtD
Imatinib—CYP3A7—Dexamethasone—psoriatic arthritis	0.0291	0.0446	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0291	0.0446	CbGbCtD
Imatinib—CYP2C19—Prednisone—psoriatic arthritis	0.0282	0.0432	CbGbCtD
Imatinib—ABCB1—Betamethasone—psoriatic arthritis	0.0244	0.0374	CbGbCtD
Imatinib—ABCB1—Prednisolone—psoriatic arthritis	0.0241	0.0369	CbGbCtD
Imatinib—ABCB1—Prednisone—psoriatic arthritis	0.0227	0.0349	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0225	0.0345	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—psoriatic arthritis	0.0218	0.0335	CbGbCtD
Imatinib—ALB—Methotrexate—psoriatic arthritis	0.0218	0.0335	CbGbCtD
Imatinib—CYP2C19—Dexamethasone—psoriatic arthritis	0.0176	0.027	CbGbCtD
Imatinib—CYP3A4—Triamcinolone—psoriatic arthritis	0.017	0.0261	CbGbCtD
Imatinib—CYP2C9—Dexamethasone—psoriatic arthritis	0.0146	0.0224	CbGbCtD
Imatinib—CYP3A4—Betamethasone—psoriatic arthritis	0.0146	0.0224	CbGbCtD
Imatinib—CYP3A4—Prednisolone—psoriatic arthritis	0.0144	0.0221	CbGbCtD
Imatinib—ABCB1—Dexamethasone—psoriatic arthritis	0.0142	0.0218	CbGbCtD
Imatinib—CYP3A4—Prednisone—psoriatic arthritis	0.0136	0.0209	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—psoriatic arthritis	0.0134	0.0205	CbGbCtD
Imatinib—ABCB1—Methotrexate—psoriatic arthritis	0.0114	0.0175	CbGbCtD
Imatinib—CYP3A4—Dexamethasone—psoriatic arthritis	0.00851	0.0131	CbGbCtD
Imatinib—ORM1—vertebral column—psoriatic arthritis	0.000671	0.184	CbGeAlD
Imatinib—ABCA3—tendon—psoriatic arthritis	0.000318	0.0872	CbGeAlD
Imatinib—DDR1—tendon—psoriatic arthritis	0.000293	0.0805	CbGeAlD
Imatinib—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000208	0.000604	CcSEcCtD
Imatinib—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000208	0.000604	CcSEcCtD
Imatinib—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000208	0.000603	CcSEcCtD
Imatinib—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000208	0.000603	CcSEcCtD
Imatinib—Epistaxis—Methotrexate—psoriatic arthritis	0.000208	0.000603	CcSEcCtD
Imatinib—Paraesthesia—Prednisolone—psoriatic arthritis	0.000208	0.000603	CcSEcCtD
Imatinib—Tachycardia—Triamcinolone—psoriatic arthritis	0.000208	0.000602	CcSEcCtD
Imatinib—Mental disorder—Prednisone—psoriatic arthritis	0.000207	0.000601	CcSEcCtD
Imatinib—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000207	0.000601	CcSEcCtD
Imatinib—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000206	0.000598	CcSEcCtD
Imatinib—Erythema—Prednisone—psoriatic arthritis	0.000206	0.000598	CcSEcCtD
Imatinib—Malnutrition—Prednisone—psoriatic arthritis	0.000206	0.000598	CcSEcCtD
Imatinib—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000206	0.000597	CcSEcCtD
Imatinib—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000206	0.000596	CcSEcCtD
Imatinib—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000205	0.000595	CcSEcCtD
Imatinib—Convulsion—Betamethasone—psoriatic arthritis	0.000205	0.000595	CcSEcCtD
Imatinib—Convulsion—Dexamethasone—psoriatic arthritis	0.000205	0.000595	CcSEcCtD
Imatinib—Hypertension—Betamethasone—psoriatic arthritis	0.000204	0.000593	CcSEcCtD
Imatinib—Hypertension—Dexamethasone—psoriatic arthritis	0.000204	0.000593	CcSEcCtD
Imatinib—Myalgia—Dexamethasone—psoriatic arthritis	0.000201	0.000584	CcSEcCtD
Imatinib—Myalgia—Betamethasone—psoriatic arthritis	0.000201	0.000584	CcSEcCtD
Imatinib—Anxiety—Betamethasone—psoriatic arthritis	0.000201	0.000582	CcSEcCtD
Imatinib—Anxiety—Dexamethasone—psoriatic arthritis	0.000201	0.000582	CcSEcCtD
Imatinib—Discomfort—Dexamethasone—psoriatic arthritis	0.000199	0.000577	CcSEcCtD
Imatinib—Discomfort—Betamethasone—psoriatic arthritis	0.000199	0.000577	CcSEcCtD
Imatinib—Haemoglobin—Methotrexate—psoriatic arthritis	0.000199	0.000577	CcSEcCtD
Imatinib—Hypotension—Methylprednisolone—psoriatic arthritis	0.000198	0.000576	CcSEcCtD
Imatinib—Pain—Prednisolone—psoriatic arthritis	0.000198	0.000574	CcSEcCtD
Imatinib—Haemorrhage—Methotrexate—psoriatic arthritis	0.000198	0.000574	CcSEcCtD
Imatinib—Hepatitis—Methotrexate—psoriatic arthritis	0.000198	0.000574	CcSEcCtD
Imatinib—Pharyngitis—Methotrexate—psoriatic arthritis	0.000196	0.000569	CcSEcCtD
Imatinib—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000195	0.000567	CcSEcCtD
Imatinib—Vision blurred—Prednisone—psoriatic arthritis	0.000194	0.000563	CcSEcCtD
Imatinib—Urethral disorder—Methotrexate—psoriatic arthritis	0.000194	0.000562	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000194	0.000562	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000193	0.000561	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000193	0.00056	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000193	0.00056	CcSEcCtD
Imatinib—Oedema—Dexamethasone—psoriatic arthritis	0.000193	0.00056	CcSEcCtD
Imatinib—Oedema—Betamethasone—psoriatic arthritis	0.000193	0.00056	CcSEcCtD
Imatinib—Insomnia—Triamcinolone—psoriatic arthritis	0.000192	0.000558	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—psoriatic arthritis	0.000192	0.000557	CcSEcCtD
Imatinib—Infection—Dexamethasone—psoriatic arthritis	0.000192	0.000556	CcSEcCtD
Imatinib—Infection—Betamethasone—psoriatic arthritis	0.000192	0.000556	CcSEcCtD
Imatinib—ABL2—tendon—psoriatic arthritis	0.000191	0.0525	CbGeAlD
Imatinib—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000191	0.000555	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000191	0.000554	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000191	0.000553	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000191	0.000553	CcSEcCtD
Imatinib—Anaemia—Prednisone—psoriatic arthritis	0.00019	0.000552	CcSEcCtD
Imatinib—Shock—Dexamethasone—psoriatic arthritis	0.00019	0.000551	CcSEcCtD
Imatinib—Shock—Betamethasone—psoriatic arthritis	0.00019	0.000551	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00019	0.00055	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000189	0.000549	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000189	0.000549	CcSEcCtD
Imatinib—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000189	0.000548	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000189	0.000548	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—psoriatic arthritis	0.000188	0.000547	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—psoriatic arthritis	0.000188	0.000547	CcSEcCtD
Imatinib—Angioedema—Prednisone—psoriatic arthritis	0.000188	0.000546	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000187	0.000543	CcSEcCtD
Imatinib—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000187	0.000543	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000187	0.000542	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000187	0.000541	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000187	0.000541	CcSEcCtD
Imatinib—Malaise—Prednisone—psoriatic arthritis	0.000186	0.000539	CcSEcCtD
Imatinib—Vertigo—Prednisone—psoriatic arthritis	0.000185	0.000537	CcSEcCtD
Imatinib—Eye disorder—Methotrexate—psoriatic arthritis	0.000185	0.000536	CcSEcCtD
Imatinib—Syncope—Prednisone—psoriatic arthritis	0.000185	0.000536	CcSEcCtD
Imatinib—Tinnitus—Methotrexate—psoriatic arthritis	0.000184	0.000535	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—psoriatic arthritis	0.000184	0.000534	CcSEcCtD
Imatinib—Anorexia—Betamethasone—psoriatic arthritis	0.000184	0.000534	CcSEcCtD
Imatinib—Urticaria—Prednisolone—psoriatic arthritis	0.000184	0.000533	CcSEcCtD
Imatinib—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000184	0.000533	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—psoriatic arthritis	0.000183	0.000532	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—psoriatic arthritis	0.000183	0.000531	CcSEcCtD
Imatinib—Pain—Triamcinolone—psoriatic arthritis	0.000182	0.000528	CcSEcCtD
Imatinib—Loss of consciousness—Prednisone—psoriatic arthritis	0.000181	0.000525	CcSEcCtD
Imatinib—PIP4K2C—tendon—psoriatic arthritis	0.000181	0.0497	CbGeAlD
Imatinib—Hypotension—Betamethasone—psoriatic arthritis	0.00018	0.000523	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—psoriatic arthritis	0.00018	0.000523	CcSEcCtD
Imatinib—Angiopathy—Methotrexate—psoriatic arthritis	0.000179	0.000521	CcSEcCtD
Imatinib—Immune system disorder—Methotrexate—psoriatic arthritis	0.000179	0.000518	CcSEcCtD
Imatinib—Convulsion—Prednisone—psoriatic arthritis	0.000178	0.000518	CcSEcCtD
Imatinib—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000178	0.000517	CcSEcCtD
Imatinib—Hypertension—Prednisone—psoriatic arthritis	0.000178	0.000516	CcSEcCtD
Imatinib—Chills—Methotrexate—psoriatic arthritis	0.000177	0.000515	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000176	0.00051	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000176	0.00051	CcSEcCtD
Imatinib—Myalgia—Prednisone—psoriatic arthritis	0.000175	0.000509	CcSEcCtD
Imatinib—Arthralgia—Prednisone—psoriatic arthritis	0.000175	0.000509	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000175	0.000509	CcSEcCtD
Imatinib—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000175	0.000508	CcSEcCtD
Imatinib—Anxiety—Prednisone—psoriatic arthritis	0.000175	0.000507	CcSEcCtD
Imatinib—Alopecia—Methotrexate—psoriatic arthritis	0.000175	0.000507	CcSEcCtD
Imatinib—Insomnia—Betamethasone—psoriatic arthritis	0.000175	0.000507	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—psoriatic arthritis	0.000175	0.000507	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000174	0.000505	CcSEcCtD
Imatinib—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000174	0.000504	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000173	0.000503	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—psoriatic arthritis	0.000173	0.000503	CcSEcCtD
Imatinib—Discomfort—Prednisone—psoriatic arthritis	0.000173	0.000503	CcSEcCtD
Imatinib—Mental disorder—Methotrexate—psoriatic arthritis	0.000173	0.000503	CcSEcCtD
Imatinib—CA3—tendon—psoriatic arthritis	0.000173	0.0474	CbGeAlD
Imatinib—Erythema—Methotrexate—psoriatic arthritis	0.000172	0.000499	CcSEcCtD
Imatinib—Malnutrition—Methotrexate—psoriatic arthritis	0.000172	0.000499	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00017	0.000495	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00017	0.000493	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—psoriatic arthritis	0.00017	0.000493	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—psoriatic arthritis	0.000169	0.00049	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—psoriatic arthritis	0.000169	0.000489	CcSEcCtD
Imatinib—Dysgeusia—Methotrexate—psoriatic arthritis	0.000169	0.000489	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000168	0.000488	CcSEcCtD
Imatinib—Oedema—Prednisone—psoriatic arthritis	0.000168	0.000488	CcSEcCtD
Imatinib—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000168	0.000488	CcSEcCtD
Imatinib—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000168	0.000487	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—psoriatic arthritis	0.000168	0.000487	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000168	0.000487	CcSEcCtD
Imatinib—Infection—Prednisone—psoriatic arthritis	0.000167	0.000485	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000167	0.000484	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000167	0.000484	CcSEcCtD
Imatinib—Back pain—Methotrexate—psoriatic arthritis	0.000167	0.000483	CcSEcCtD
Imatinib—Fatigue—Betamethasone—psoriatic arthritis	0.000166	0.000483	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—psoriatic arthritis	0.000166	0.000483	CcSEcCtD
Imatinib—CA9—tendon—psoriatic arthritis	0.000165	0.0454	CbGeAlD
Imatinib—Shock—Prednisone—psoriatic arthritis	0.000165	0.00048	CcSEcCtD
Imatinib—Pain—Dexamethasone—psoriatic arthritis	0.000165	0.000479	CcSEcCtD
Imatinib—Pain—Betamethasone—psoriatic arthritis	0.000165	0.000479	CcSEcCtD
Imatinib—Nervous system disorder—Prednisone—psoriatic arthritis	0.000165	0.000478	CcSEcCtD
Imatinib—Tachycardia—Prednisone—psoriatic arthritis	0.000164	0.000476	CcSEcCtD
Imatinib—Skin disorder—Prednisone—psoriatic arthritis	0.000163	0.000474	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000163	0.000472	CcSEcCtD
Imatinib—Vision blurred—Methotrexate—psoriatic arthritis	0.000162	0.000471	CcSEcCtD
Imatinib—Anorexia—Prednisone—psoriatic arthritis	0.00016	0.000465	CcSEcCtD
Imatinib—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00016	0.000463	CcSEcCtD
Imatinib—Anaemia—Methotrexate—psoriatic arthritis	0.000159	0.000462	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000159	0.000462	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000159	0.000462	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000158	0.000458	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000158	0.000458	CcSEcCtD
Imatinib—CA14—tendon—psoriatic arthritis	0.000157	0.0431	CbGeAlD
Imatinib—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000157	0.000455	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000156	0.000454	CcSEcCtD
Imatinib—Malaise—Methotrexate—psoriatic arthritis	0.000155	0.00045	CcSEcCtD
Imatinib—Vertigo—Methotrexate—psoriatic arthritis	0.000155	0.000449	CcSEcCtD
Imatinib—Leukopenia—Methotrexate—psoriatic arthritis	0.000154	0.000447	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—psoriatic arthritis	0.000153	0.000445	CcSEcCtD
Imatinib—Urticaria—Betamethasone—psoriatic arthritis	0.000153	0.000445	CcSEcCtD
Imatinib—CSF1R—skin of body—psoriatic arthritis	0.000153	0.0421	CbGeAlD
Imatinib—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000153	0.000444	CcSEcCtD
Imatinib—Dizziness—Prednisolone—psoriatic arthritis	0.000153	0.000444	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—psoriatic arthritis	0.000153	0.000443	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—psoriatic arthritis	0.000153	0.000443	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000153	0.000443	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000153	0.000443	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—psoriatic arthritis	0.000153	0.000443	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—psoriatic arthritis	0.000152	0.000442	CcSEcCtD
Imatinib—Insomnia—Prednisone—psoriatic arthritis	0.000152	0.000441	CcSEcCtD
Imatinib—Paraesthesia—Prednisone—psoriatic arthritis	0.000151	0.000438	CcSEcCtD
Imatinib—Pruritus—Triamcinolone—psoriatic arthritis	0.000151	0.000437	CcSEcCtD
Imatinib—Cough—Methotrexate—psoriatic arthritis	0.00015	0.000436	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—psoriatic arthritis	0.00015	0.000436	CcSEcCtD
Imatinib—Convulsion—Methotrexate—psoriatic arthritis	0.000149	0.000433	CcSEcCtD
Imatinib—Dyspepsia—Prednisone—psoriatic arthritis	0.000148	0.000429	CcSEcCtD
Imatinib—Myalgia—Methotrexate—psoriatic arthritis	0.000147	0.000425	CcSEcCtD
Imatinib—Chest pain—Methotrexate—psoriatic arthritis	0.000147	0.000425	CcSEcCtD
Imatinib—Arthralgia—Methotrexate—psoriatic arthritis	0.000147	0.000425	CcSEcCtD
Imatinib—Decreased appetite—Prednisone—psoriatic arthritis	0.000146	0.000424	CcSEcCtD
Imatinib—Rash—Prednisolone—psoriatic arthritis	0.000146	0.000423	CcSEcCtD
Imatinib—Dermatitis—Prednisolone—psoriatic arthritis	0.000146	0.000423	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000146	0.000422	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000145	0.000421	CcSEcCtD
Imatinib—Fatigue—Prednisone—psoriatic arthritis	0.000145	0.000421	CcSEcCtD
Imatinib—Headache—Prednisolone—psoriatic arthritis	0.000145	0.000421	CcSEcCtD
Imatinib—Discomfort—Methotrexate—psoriatic arthritis	0.000145	0.00042	CcSEcCtD
Imatinib—Constipation—Prednisone—psoriatic arthritis	0.000144	0.000417	CcSEcCtD
Imatinib—Confusional state—Methotrexate—psoriatic arthritis	0.000142	0.000411	CcSEcCtD
Imatinib—Dizziness—Triamcinolone—psoriatic arthritis	0.000141	0.000408	CcSEcCtD
Imatinib—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00014	0.000408	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—psoriatic arthritis	0.00014	0.000407	CcSEcCtD
Imatinib—Infection—Methotrexate—psoriatic arthritis	0.00014	0.000405	CcSEcCtD
Imatinib—KIT—skin of body—psoriatic arthritis	0.000139	0.0382	CbGeAlD
Imatinib—Feeling abnormal—Prednisone—psoriatic arthritis	0.000139	0.000402	CcSEcCtD
Imatinib—Asthenia—Dexamethasone—psoriatic arthritis	0.000138	0.000402	CcSEcCtD
Imatinib—Asthenia—Betamethasone—psoriatic arthritis	0.000138	0.000402	CcSEcCtD
Imatinib—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000138	0.0004	CcSEcCtD
Imatinib—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000138	0.000399	CcSEcCtD
Imatinib—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000137	0.000399	CcSEcCtD
Imatinib—Nausea—Prednisolone—psoriatic arthritis	0.000137	0.000399	CcSEcCtD
Imatinib—Pruritus—Betamethasone—psoriatic arthritis	0.000137	0.000396	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—psoriatic arthritis	0.000137	0.000396	CcSEcCtD
Imatinib—Skin disorder—Methotrexate—psoriatic arthritis	0.000136	0.000396	CcSEcCtD
Imatinib—PDGFRB—skin of body—psoriatic arthritis	0.000136	0.0373	CbGeAlD
Imatinib—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000136	0.000394	CcSEcCtD
Imatinib—Vomiting—Triamcinolone—psoriatic arthritis	0.000135	0.000392	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—psoriatic arthritis	0.000135	0.000392	CcSEcCtD
Imatinib—Rash—Triamcinolone—psoriatic arthritis	0.000134	0.000389	CcSEcCtD
Imatinib—Dermatitis—Triamcinolone—psoriatic arthritis	0.000134	0.000389	CcSEcCtD
Imatinib—Anorexia—Methotrexate—psoriatic arthritis	0.000134	0.000389	CcSEcCtD
Imatinib—Rash—Methylprednisolone—psoriatic arthritis	0.000134	0.000388	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000134	0.000388	CcSEcCtD
Imatinib—Urticaria—Prednisone—psoriatic arthritis	0.000134	0.000387	CcSEcCtD
Imatinib—Headache—Triamcinolone—psoriatic arthritis	0.000133	0.000387	CcSEcCtD
Imatinib—Headache—Methylprednisolone—psoriatic arthritis	0.000133	0.000386	CcSEcCtD
Imatinib—NQO2—tendon—psoriatic arthritis	0.000133	0.0365	CbGeAlD
Imatinib—Abdominal pain—Prednisone—psoriatic arthritis	0.000133	0.000386	CcSEcCtD
Imatinib—Body temperature increased—Prednisone—psoriatic arthritis	0.000133	0.000386	CcSEcCtD
Imatinib—PDGFRA—tendon—psoriatic arthritis	0.000133	0.0364	CbGeAlD
Imatinib—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000132	0.000383	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—psoriatic arthritis	0.000132	0.000383	CcSEcCtD
Imatinib—Hypotension—Methotrexate—psoriatic arthritis	0.000131	0.000381	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000128	0.000371	CcSEcCtD
Imatinib—Dizziness—Betamethasone—psoriatic arthritis	0.000128	0.00037	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—psoriatic arthritis	0.000128	0.00037	CcSEcCtD
Imatinib—Insomnia—Methotrexate—psoriatic arthritis	0.000127	0.000369	CcSEcCtD
Imatinib—Nausea—Triamcinolone—psoriatic arthritis	0.000126	0.000367	CcSEcCtD
Imatinib—Paraesthesia—Methotrexate—psoriatic arthritis	0.000126	0.000366	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—psoriatic arthritis	0.000126	0.000366	CcSEcCtD
Imatinib—Dyspnoea—Methotrexate—psoriatic arthritis	0.000125	0.000363	CcSEcCtD
Imatinib—Somnolence—Methotrexate—psoriatic arthritis	0.000125	0.000362	CcSEcCtD
Imatinib—Hypersensitivity—Prednisone—psoriatic arthritis	0.000124	0.000359	CcSEcCtD
Imatinib—Dyspepsia—Methotrexate—psoriatic arthritis	0.000124	0.000359	CcSEcCtD
Imatinib—Vomiting—Dexamethasone—psoriatic arthritis	0.000123	0.000356	CcSEcCtD
Imatinib—Vomiting—Betamethasone—psoriatic arthritis	0.000123	0.000356	CcSEcCtD
Imatinib—Decreased appetite—Methotrexate—psoriatic arthritis	0.000122	0.000354	CcSEcCtD
Imatinib—Rash—Dexamethasone—psoriatic arthritis	0.000122	0.000353	CcSEcCtD
Imatinib—Rash—Betamethasone—psoriatic arthritis	0.000122	0.000353	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—psoriatic arthritis	0.000122	0.000353	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—psoriatic arthritis	0.000122	0.000353	CcSEcCtD
Imatinib—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000121	0.000352	CcSEcCtD
Imatinib—ABL1—skin of body—psoriatic arthritis	0.000121	0.0333	CbGeAlD
Imatinib—Fatigue—Methotrexate—psoriatic arthritis	0.000121	0.000351	CcSEcCtD
Imatinib—Headache—Betamethasone—psoriatic arthritis	0.000121	0.000351	CcSEcCtD
Imatinib—Headache—Dexamethasone—psoriatic arthritis	0.000121	0.000351	CcSEcCtD
Imatinib—Asthenia—Prednisone—psoriatic arthritis	0.000121	0.00035	CcSEcCtD
Imatinib—Pain—Methotrexate—psoriatic arthritis	0.00012	0.000349	CcSEcCtD
Imatinib—Pruritus—Prednisone—psoriatic arthritis	0.000119	0.000345	CcSEcCtD
Imatinib—CSF1R—tendon—psoriatic arthritis	0.000117	0.032	CbGeAlD
Imatinib—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000116	0.000336	CcSEcCtD
Imatinib—Diarrhoea—Prednisone—psoriatic arthritis	0.000115	0.000334	CcSEcCtD
Imatinib—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000115	0.000333	CcSEcCtD
Imatinib—Nausea—Betamethasone—psoriatic arthritis	0.000115	0.000333	CcSEcCtD
Imatinib—Nausea—Dexamethasone—psoriatic arthritis	0.000115	0.000333	CcSEcCtD
Imatinib—Urticaria—Methotrexate—psoriatic arthritis	0.000112	0.000324	CcSEcCtD
Imatinib—Dizziness—Prednisone—psoriatic arthritis	0.000111	0.000323	CcSEcCtD
Imatinib—Abdominal pain—Methotrexate—psoriatic arthritis	0.000111	0.000322	CcSEcCtD
Imatinib—Body temperature increased—Methotrexate—psoriatic arthritis	0.000111	0.000322	CcSEcCtD
Imatinib—Vomiting—Prednisone—psoriatic arthritis	0.000107	0.00031	CcSEcCtD
Imatinib—SLC47A1—tendon—psoriatic arthritis	0.000107	0.0293	CbGeAlD
Imatinib—Rash—Prednisone—psoriatic arthritis	0.000106	0.000308	CcSEcCtD
Imatinib—Dermatitis—Prednisone—psoriatic arthritis	0.000106	0.000307	CcSEcCtD
Imatinib—Headache—Prednisone—psoriatic arthritis	0.000105	0.000306	CcSEcCtD
Imatinib—PDGFRB—tendon—psoriatic arthritis	0.000104	0.0284	CbGeAlD
Imatinib—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000104	0.0003	CcSEcCtD
Imatinib—Asthenia—Methotrexate—psoriatic arthritis	0.000101	0.000292	CcSEcCtD
Imatinib—Nausea—Prednisone—psoriatic arthritis	9.99e-05	0.00029	CcSEcCtD
Imatinib—Pruritus—Methotrexate—psoriatic arthritis	9.94e-05	0.000288	CcSEcCtD
Imatinib—Diarrhoea—Methotrexate—psoriatic arthritis	9.61e-05	0.000279	CcSEcCtD
Imatinib—Dizziness—Methotrexate—psoriatic arthritis	9.29e-05	0.00027	CcSEcCtD
Imatinib—ABL1—tendon—psoriatic arthritis	9.23e-05	0.0253	CbGeAlD
Imatinib—Vomiting—Methotrexate—psoriatic arthritis	8.93e-05	0.000259	CcSEcCtD
Imatinib—Rash—Methotrexate—psoriatic arthritis	8.86e-05	0.000257	CcSEcCtD
Imatinib—Dermatitis—Methotrexate—psoriatic arthritis	8.85e-05	0.000257	CcSEcCtD
Imatinib—Headache—Methotrexate—psoriatic arthritis	8.8e-05	0.000255	CcSEcCtD
Imatinib—Nausea—Methotrexate—psoriatic arthritis	8.34e-05	0.000242	CcSEcCtD
Imatinib—CA2—skin of body—psoriatic arthritis	8.25e-05	0.0227	CbGeAlD
Imatinib—PTGS1—skin of body—psoriatic arthritis	6.37e-05	0.0175	CbGeAlD
Imatinib—CA2—tendon—psoriatic arthritis	6.28e-05	0.0173	CbGeAlD
Imatinib—PTGS1—tendon—psoriatic arthritis	4.85e-05	0.0133	CbGeAlD
